The proteome of the locus ceruleus in Parkinson's disease: Relevance to pathogenesis

Brain Pathology

Volumn 22, Issue 4, 2012, Pages 485-498

  Van Dijk, Karin D ^a   Berendse, Henk W ^a   Drukarch, Benjamin ^a   Fratantoni, Silvina A ^a   Pham, Thang V ^a   Piersma, Sander R ^a   Huisman, Evelien ^a   Brevé, John J P ^a   Groenewegen, Henk J ^a   Jimenez, Connie R ^a   Van De Berg, Wilma D J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aminoacyl tRNA synthetases; Brain proteins; Human post mortem tissue; Neurodegenerative diseases; Noradrenalin

Indexed keywords

AMINOACYL TRANSFER RNA; REGUCALCIN;

ADULT; AGED; ARTICLE; AUTOPSY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL TRANSPORT; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENDER; HUMAN; HUMAN TISSUE; INFLAMMATION; INFORMATION PROCESSING; LOCUS CERULEUS; MALE; MICROTUBULE; MITOCHONDRION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; RNA SYNTHESIS;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; COMET ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; PARKINSON DISEASE; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 84861563285     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00540.x     Document Type: Article

References (58)

1. Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I et al (2009) Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635-652.
2. Alberio T, Bossi AM, Milli A, Parma E, Gariboldi MB, Tosi G et al (2010) Proteomic analysis of dopamine and alpha-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. FEBS J 277:4909-4919.
3. Albrethsen J, Knol JC, Piersma SR, Pham TV, deWit M, Mongera S et al (2010) Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol Cell Proteomics 9:988-1005.
4. Anelli T, Alessio M, Mezghrani A, Simmen T, Talamo F, Bachi A et al (2002) ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family. EMBO J 21:835-844. (Pubitemid 34174063)
5. Antonellis A, Green ED (2008) The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 9:87-107.
6. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29. (Pubitemid 30257031)
7. Basso M, Giraudo S, Lopiano L, Bergamasco B, Bosticco E, Cinquepalmi A et al (2003) Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. Neurol Sci 24:155-156. (Pubitemid 37304289)
8. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M (2004) Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4:3943-3952. (Pubitemid 39657469)
9. Benarroch EE, Schmeichel AM, Low PA, Sandroni P, Parisi JE (2008) Loss of A5 noradrenergic neurons in multiple system atrophy. Acta Neuropathol 115:629-634.
10. Bertrand E, Lechowicz W, Szpak GM, Dymecki J (1997) Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease. Folia Neuropathol 35:80-86. (Pubitemid 127535387)
11. Borges JC, Fischer H, Craievich AF, Hansen LD, Ramos CH (2003) Free human mitochondrial GrpE is a symmetric dimer in solution. J Biol Chem 278:35337-35344. (Pubitemid 37102302)
12. Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF et al (2009) Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 19:91-107.
13. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259.
14. Braak H, Del TK, Rub U, deVos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211. (Pubitemid 36007810)
15. Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J (2010) Using "omics" to define pathogenesis and biomarkers of Parkinson's disease. Expert Rev Neurother 10:925-942.
16. DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI et al (2008) Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet 124:95-99.
17. Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F (2010) Oxidative stress and plasma aminopeptidase activity in Huntington's disease. J Neural Transm 117:325-332.
18. Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F (2011) Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment. Neurodegener Dis 8:109-116.
19. Galea E, Heneka MT, Dello RC, Feinstein DL (2003) Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol 23:625-635. (Pubitemid 37071489)
20. German DC, Manaye KF, White CL III,Woodward DJ, McIntire DD, Smith WK et al (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667-676.
21. Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F (2000) The role of the locus coeruleus in the development of Parkinson's disease. Neurosci Biobehav Rev 24:655-668. (Pubitemid 30625131)
22. Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J et al (2002) A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 52:549-555. (Pubitemid 35246857)
23. Hirokawa N, Niwa S, Tanaka Y (2010) Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 68:610-638.
24. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382-397.
25. Jin J, Hulette C,Wang Y, Zhang T, Pan C,Wadhwa R et al (2006) Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol Cell Proteomics 5:1193-1204. (Pubitemid 44103391)
26. Jordanova A, Irobi J, Thomas FP, Van DP, Meerschaert K, Dewil M et al (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38:197-202. (Pubitemid 43177233)
27. Keller A, Nesvizhskii AI, Kolker E, Aebersold R (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74:5383-5392. (Pubitemid 35215372)
28. Kenmochi N, Suzuki T, Uechi T, Magoori M, Kuniba M, Higa S et al (2001) The human mitochondrial ribosomal protein genes: mapping of 54 genes to the chromosomes and implications for human disorders. Genomics 77:65-70. (Pubitemid 32826487)
29. Kim JM, Lee KH, Jeon YJ, Oh JH, Jeong SY, Song IS et al (2006) Identification of genes related to Parkinson's disease using expressed sequence tags. DNA Res 13:275-286.
30. Kitsou E, Pan S, Zhang J, Shi M, Zabeti A, Dickson DWet al (2008) Identification of proteins in human substantia nigra. Proteomics Clin Appl 2:776-782. (Pubitemid 351772032)
31. Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA et al (2006) Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 443:50-55. (Pubitemid 44344044)
32. Li J, Richter K, Buchner J (2011) Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle. Nat Struct Mol Biol 18:61-66.
33. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA et al (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70:985-993. (Pubitemid 34259314)
34. Lin L, Lesnick TG, Maraganore DM, Isacson O (2009) Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci 32:142-149.
35. Mila S, Albo AG, Corpillo D, Giraudo S, Zibetti M, Bucci EM et al (2009) Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress. Biomark Med 3:117-128.
36. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
37. Nesvizhskii AI, Keller A, Kolker E, Aebersold R (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646-4658. (Pubitemid 37082259)
38. Noureddine MA, Qin XJ, Oliveira SA, Skelly TJ, van derWalt J, Hauser MA et al (2005) Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum Genet 117:27-33. (Pubitemid 40778779)
39. Papapetropoulos S, Ffrench-Mullen J, McCorquodale D, Qin Y, Pablo J, Mash DC (2006) Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. Gene Expr 13:205-215. (Pubitemid 351426385)
40. Park SG, Ewalt KL, Kim S (2005) Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 30:569-574. (Pubitemid 41356495)
41. Petrak J, Ivanek R, Toman O, Cmejla R, Cmejlova J, Vyoral D et al (2008) Deja vu in proteomics.A hit parade of repeatedly identified differentially expressed proteins. Proteomics 8:1744-1749. (Pubitemid 351678270)
42. Pham TV, Piersma SR,Warmoes M, Jimenez CR (2010) On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. Bioinformatics 26:363-369.
43. Piersma SR, Fiedler U, Span S, Lingnau A, Pham TV, Hoffmann S et al (2010)Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum. J Proteome Res 9:1913-1922.
44. Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, Friis S (2010) L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol 67:600-606.
45. Samuels ER, Szabadi E (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 6:235-253.
46. Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7:97-109.
47. Shadrina M, Nikopensius T, Slominsky P, Illarioshkin S, Bagyeva G, Markova E et al (2006) Association study of sporadic Parkinson's disease genetic risk factors in patients from Russia by APEX technology. Neurosci Lett 405:212-216. (Pubitemid 44189719)
48. Shevchenko A,Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850-858.
49. Shi M, Jin J,Wang Y, Beyer RP, Kitsou E, Albin RL et al (2008) Mortalin: a protein associated with progression of Parkinson disease? J Neuropathol Exp Neurol 67:117-124.
50. Shi M, Bradner J, Bammler TK, Eaton DL, Zhang J, Ye Z et al (2009) Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am J Pathol 175:54-65.
51. Tong J,Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M et al (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain 133:172-188.
52. Totani K, Ihara Y, Tsujimoto T, Matsuo I, Ito Y (2009) The recognition motif of the glycoprotein-folding sensor enzyme UDP-Glc:glycoprotein glucosyltransferase. Biochemistry 48:2933-2940.
53. Toyoshima I, Yu H, Steuer ER, Sheetz MP (1992) Kinectin, a major kinesin-binding protein on ER. J Cell Biol 118:1121-1131.
54. Vale RD (2003) The molecular motor toolbox for intracellular transport. Cell 112:467-480.
55. van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, Berendse HW et al (2010) Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach. Neurobiol Dis 39:229-241.
56. Werner CJ, Heyny-von HR, Mall G,Wolf S (2008) Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci 6:8.
57. Yamaguchi M (2005) Role of regucalcin in maintaining cell homeostasis and function (review). Int J Mol Med 15:371-389.
58. Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC (1993) The locus ceruleus and dementia in Parkinson's disease. Neurology 43:986-991. (Pubitemid 23150574)